2 Stocks Under $50 on Our Watchlist and 1 That Underwhelm
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1%
Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m. ET
Barchart Research What to Expect from ASTH Earnings ASTH Generated August 5, 2026 Current Price $35.83 EPS Estimate $$0.33 Consensus Rating Strong Buy Average Move 16.20% Astrana Health's Risk-Heavy Growth...
Astrana Health (ASTH) Q2 Earnings: What To Expect
2 Reasons to Like ASTH and 1 to Stay Skeptical
ALHAMBRA, Calif. , July 14, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, technology-enabled...
Names Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise Transformation